Stabilized transdermal drug delivery system
    3.
    发明授权
    Stabilized transdermal drug delivery system 有权
    稳定的透皮给药系统

    公开(公告)号:US09226902B2

    公开(公告)日:2016-01-05

    申请号:US12475390

    申请日:2009-05-29

    申请人: Jiashang Tang

    发明人: Jiashang Tang

    IPC分类号: A61F13/02 A61K9/70

    摘要: A solid dispersion transdermal drug delivery system comprising a therapeutic agent in a stable amorphous form and a combination polymeric stabilizing and dispersing agent having a hydrogen bond-forming functional group, and a method of manufacturing these systems is provided. The weight ratio of the combination polymeric stabilizing and dispersing agent to the therapeutic agent is also disclosed.

    摘要翻译: 提供了包含稳定无定形形式的治疗剂和具有形成氢键的官能团的聚合稳定分散剂的固体分散透皮药物递送系统及其制造方法。 还公开了组合聚合物稳定剂和分散剂与治疗剂的重量比。

    EXTENDED-RELEASE DOSAGE FORM
    7.
    发明申请
    EXTENDED-RELEASE DOSAGE FORM 审中-公开
    扩展释放剂量表

    公开(公告)号:US20110123613A1

    公开(公告)日:2011-05-26

    申请号:US12977713

    申请日:2010-12-23

    摘要: Provided are pharmaceutical formulations comprising sustained release particles each having an inner core bead comprising an active pharmaceutical ingredient an intermediate coating substantially surrounding the inner core bead, and an outer coating substantially surrounding the intermediate coating comprising a pH independent polymer. Also provided is a pharmaceutical formulation comprising two bead populations wherein each of the first and second bead populations have a different drug release profile. Also provided is a method of preparing an extended release dosage composition comprising one or more bead populations.

    摘要翻译: 提供了包含持续释放颗粒的药物制剂,其各自具有包含活性药物成分的内芯珠,基本上围绕内芯珠的中间涂层,以及基本上围绕包含pH独立聚合物的中间涂层的外涂层。 还提供了包含两个珠粒的药物制剂,其中第一和第二珠粒中的每一个具有不同的药物释放曲线。 还提供了制备包含一个或多个珠粒的延长释放剂量组合物的方法。

    STABILIZED TRANSDERMAL DRUG DELIVERY SYSTEM
    8.
    发明申请
    STABILIZED TRANSDERMAL DRUG DELIVERY SYSTEM 有权
    稳定的超导药物递送系统

    公开(公告)号:US20090299304A1

    公开(公告)日:2009-12-03

    申请号:US12475390

    申请日:2009-05-29

    申请人: Jiashang Tang

    发明人: Jiashang Tang

    IPC分类号: A61M35/00 A61K9/70

    摘要: A solid dispersion transdermal drug delivery system comprising a therapeutic agent in a stable amorphous form and a combination polymeric stabilizing and dispersing agent having a hydrogen bond-forming functional group, and a method of manufacturing these systems is provided. The weight ratio of the combination polymeric stabilizing and dispersing agent to the therapeutic agent is also disclosed.

    摘要翻译: 提供了包含稳定无定形形式的治疗剂和具有形成氢键的官能团的聚合稳定分散剂的固体分散透皮药物递送系统及其制造方法。 还公开了组合聚合物稳定剂和分散剂与治疗剂的重量比。

    Amorphous drug transdermal systems, manufacturing methods, and stabilization
    9.
    发明申请
    Amorphous drug transdermal systems, manufacturing methods, and stabilization 审中-公开
    无定形药物透皮系统,制造方法和稳定性

    公开(公告)号:US20080226698A1

    公开(公告)日:2008-09-18

    申请号:US11725159

    申请日:2007-03-16

    CPC分类号: A61K9/7053 A61K9/7069

    摘要: The present invention refers to a transdermal delivery device comprising a backing layer, an adhesive matrix layer comprising a supersaturated concentration of an active agent substantially in amorphous form within the adhesive matrix, and a release liner. The present invention also refers to a method of preparing an adhesive matrix containing at least one supersaturated active agent substantially in amorphous form. Further, the present invention refers to a method to stabilize and a method to reestablish the meta-stable amorphous-drug transdermal system during its manufacturing, storing, shipping and handling process.

    摘要翻译: 本发明涉及一种透皮递送装置,其包括背衬层,包含过饱和浓度的基本上为无定形形式的粘合剂基质中的活性剂的粘合剂基质层和释放衬垫。 本发明还涉及制备含有至少一种基本上为无定形形式的过饱和活性剂的粘合剂基质的方法。 此外,本发明涉及一种稳定化方法以及在其制造,储存,运输和处理过程中重新建立间 - 稳定非晶药物透皮系统的方法。